Amid all the high drama surrounding last week’s elections, a smaller development could have big implications for one biotech startup. As today’s article explains, voters in Oregon approved a ballot measure that legalizes psilocybin – the hallucinogenic compound in magic mushrooms – for the treatment of mental health problems, and the biotech in question currently has a psilocybin treatment in clinical trials. For more on this biotech that appears to be an under-the-radar election winner, CLICK HERE.